Potential Pulmonary Benefit of Low Pressure Laparoscopic Cholecystectomy in Selected Patients
POPLOP
The Pulmonary Effects of Low Pressure Versus Standard Pressure Laparoscopic Cholecystectomy in Patients With Cardiopulmonary Disorders: A Prospective Randomized Controlled Trial
1 other identifier
interventional
140
1 country
1
Brief Summary
Standard Pressure Laparoscopic Cholecystectomy,as the standard for cholecystectomy, can lead to about 15% of pulmonary atelectasis. According to literature, low pressure laparoscopic cholecystectomy is thought to probably decrease cardio-pulmonary related complications and postoperative pain. However, the previous studies have presented controversial results. Our study aim to evaluate the potential pulmonary benefit of low pressure laparoscopic cholecystectomy in elderly or patients accompanied with cardio-pulmonary disorders.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jun 2019
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 10, 2019
CompletedFirst Submitted
Initial submission to the registry
November 24, 2020
CompletedFirst Posted
Study publicly available on registry
December 17, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2021
CompletedDecember 23, 2020
December 1, 2020
2.4 years
November 24, 2020
December 21, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change of partial pressure of carbon dioxide(pCO2)
Change of pCO2 in arterial blood gas test
Within postoperative 30 days.
Secondary Outcomes (4)
operation time
During surgery.
conversion rate to open surgery
During surgery.
visual analogue scale (VAS)
During postoperative 24 hours.
complication rate
Within postoperative 30 days.
Study Arms (2)
Low Pressure Laparoscopic Cholecystectomy
EXPERIMENTALLPLC refers to "Low Pressure Laparoscopic Cholecystectomy". In this arm, the pneumoperitoneum pressure is set as 10mmHg.
Standard Pressure Laparoscopic Cholecystectomy
OTHERThis is taken as the control group. SPLC refers to "Standard Pressure Laparoscopic Cholecystectomy". In this arm, the pneumoperitoneum pressure is set as 14 mmHg.
Interventions
Low Pressure Laparoscopic Cholecystectomy (10mmHg) is set as the experimental group.
Standard Pressure Laparoscopic Cholecystectomy (14mmHg) is set as the control group.
Eligibility Criteria
You may qualify if:
- Aged 18-85;
- Patients receiving laparoscopic cholecystectomy due to benign gallbladder diseases;
- Older patient or accompanied by cardiopulmonary diseases (age\>60 years, hypertension, Diabetes Mellitus, coronary heart disease, arrhythmia, chronic bronchitis, emphysema, history of heart surgery, history of lung surgery, history of mediastinal surgery, asthma, et al);
- Aged older than 60, with or without the above diseases;
- American society of Aneshesiologists (ASA) II or higher;
- Informed consent acquired.
You may not qualify if:
- Having contraindication of laparoscopic operations;
- History at epigastric surgery. -
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Peking Union Medical College Hospital
Beijing, Beijing Municipality, 100730, China
Related Publications (1)
Tian F, Sun X, Yu Y, Zhang N, Hong T, Liang L, Yao B, Song L, Pei C, Wang Y, Lu W, Qu Q, Guo J, Zhang T, He X. Comparison of low-pressure and standard-pressure pneumoperitoneum laparoscopic cholecystectomy in patients with cardiopulmonary comorbidities: a double blinded randomized clinical trial. BMC Surg. 2024 Nov 6;24(1):348. doi: 10.1186/s12893-024-02606-w.
PMID: 39506748DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Xiaodong He, Doctor
Peking Union Medical College Hospital
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Masking Details
- It will be single blinded. Operator, first assistant and data collector could not be blinded. Whereas patients, nurses, data analyzer, and those who have the access to the primary predictor will be blinded.
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Attending
Study Record Dates
First Submitted
November 24, 2020
First Posted
December 17, 2020
Study Start
June 10, 2019
Primary Completion
November 1, 2021
Study Completion
December 1, 2021
Last Updated
December 23, 2020
Record last verified: 2020-12